- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Seborrheic Dermatitis associated with Insulin Resistance: Study
Seborrheic Dermatitis associated with Insulin Resistance, suggests a study published in the Metabolic Syndrome and Related Disorders
Our knowledge of the systemic effects of seborrheic dermatitis (SD) as a chronic inflammatory skin disease remains limited.
A team of researchers aimed to evaluate metabolic syndrome (MS) and glucose metabolism disorders in patients with seborrheic dermatitis (SD).
The study includes 53 patients over the age of 18 diagnosed with seborrheic dermatitis (SD) and 50 age-, gender-, and body mass index-matched healthy controls. Demographic data, anthropometric measurements, blood pressure levels, family history of seborrheic dermatitis (SD) and metabolic disorder, smoking history, and severity of the disease in seborrheic dermatitis (SD) patients were obtained. Fasting plasma glucose, insulin, haemoglobin A1c, lipid profile levels, and two-hour plasma glucose in the oral glucose tolerance test homeostasis model assessment of insulin resistance, and presence of MS was determined.
The results of the study are as follows:
- Weight, waist circumference, family history of seborrheic dermatitis (SD), family history of metabolic disorder, and smoking status were significantly higher in seborrheic dermatitis (SD) group compared with the control group. The levels of fasting plasma insulin and triglyceride, HOMA-IR and OGTT 2-h PG were also significantly higher in seborrheic dermatitis (SD) group than in the control group
- In addition, the number of those with insulin resistance was significantly higher in the group with seborrheic dermatitis (SD) than in the control group
- Although the rate of MS was higher in patients with seborrheic dermatitis (SD) than in the controls, the difference was not significant.
Thus, the researcher concluded that findings suggest an association between SD and insulin resistance, which may be due to their common inflammatory pathogenesis. This may be an indicator of susceptibility to diabetes, and these patients can be followed up for conditions associated with insulin resistance and encouraged to adopt a healthy lifestyle.
Reference:
Insulin Resistance and Metabolic Syndrome in Patients with Seborrheic Dermatitis: A Case–Control Study by Sevil Savaş Erdoğan et al. published in the Metabolic Syndrome and Related Disorders.
Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751